AME vs VIVS · P/E 30, rev $2.04B vs P/E 0.7, rev $131.0K
Ametek Inc (AME) versus VivoSim Labs, Inc. (VIVS) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
VivoSim Labs, Inc. (VIVS) is a biotechnology company listed on NASDAQ.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported VIVS revenue for 2026-03-31 was $131.0K. Net income was -$13.8M. Revenue was down 9.0% from 2025-03-31 to 2026-03-31. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
AME currently screens at market cap $42.11B and trailing P/E 29.9. VIVS currently screens at market cap $3.5M and trailing P/E 0.7.
Not investment advice. Open the AME and VIVS stock pages for the full models.
Not investment advice.